Back to Results
First PageMeta Content
Attention-deficit hyperactivity disorder / Nootropics / Childhood psychiatric disorders / Attention / Educational psychology / Atomoxetine / Attention deficit hyperactivity disorder / Placebo / Anxiety disorder / Medicine / Chemistry / Psychiatry


Atomoxetine Treatment for Pediatric Patients with ADHD and Comorbid Anxiety Calvin Sumner, MD1; Lawrence Sher, MD2; Virginia Sutton, PhD1; Rosalie Bakken, PhD1; Martin Paczkowski, MPH1; Douglas Kelsey, MD, PhD1 Research
Add to Reading List

Document Date: 2006-03-14 13:57:28

Open Document

File Size: 42,60 KB

Share Result on Facebook

City

Washington / DC / Faries / Indianapolis / Malcolm / New York / /

Company

Gould / 2Peninsula Research Associates Inc. / Eli Lilly and Company / The Guilford Press / PhD1 Research Laboratories / /

Country

United States / /

IndustryTerm

atomoxetine / /

MedicalCondition

ADHD / Headache / Nasopharyngitis / anxiety disorders / Nausea / social phobia / anxiety disorder / separation anxiety / Vomiting / disorder / Sinusitis / Maximum Dose Headache / Cough / Influenza / disorders / /

MusicGroup

Nausea / /

Person

Martin Paczkowski / Virginia Sutton / Rosalie Bakken / Lawrence Sher / Douglas Kelsey / /

Position

Investigator / Stimulant YES Exposure NO CYP2D6 EM Genotype PM / Fisher / /

ProvinceOrState

Saskatchewan / Indiana / /

PublishedMedium

Baseline / /

Technology

Genotype / /

SocialTag